Pyridostigmine-d3 (bromide)
(Synonyms: 溴化吡啶斯的明 d3 (溴盐)) 目录号 : GC49424An internal standard for the quantification of pyridostigmine
Sample solution is provided at 25 µL, 10mM.
Pyridostigmine-d3 is intended for use as an internal standard for the quantification of pyridostigmine by GC- or LC-MS. Pyridostigmine is an inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE; IC50s = 0.35 and 1 μM, respectively, for the human enzymes).1 Pyridostigmine (10 µM) reduces decreases in AChE activity induced by the organophosphate pesticides diisopropyl fluorophosphate, chlorpyrifos-oxon, diazinon-oxon, paraoxon, and malaoxon in isolated bovine red blood cells.2 It also reduces soman-induced membrane depolarization and decreases in AChE activity in isolated human muscle bundles in a concentration-dependent manner.3 Pyridostigmine (3 mg/kg per day for four weeks) prevents tachycardia and increases in sympathetic tone in mice following myocardial infarction induced by left coronary artery ligation.4 Formulations containing pyridostigmine have been used in the treatment of myasthenia gravis and as neuromuscular protective agents against organophosphate poisoning.
1.Strelnik, A.D., Petukhov, A.S., Zueva, I.V., et al.Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profileBioorg. Med. Chem. Lett.26(16)4092-4094(2016) 2.Henderson, J.D., Glucksman, G., Leong, B., et al.Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticidesJ. Biochem. Mol. Toxicol.26(1)31-34(2012) 3.Maselli, R.A., Henderson, J.D., Ng, J., et al.Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromideMuscle Nerve43(4)591-595(2011) 4.Durand, M.T., Becari, C., de Oliveira, M., et al.Pyridostigmine restores cardiac autonomic balance after small myocardial infarction in micePLoS One9(8)e104476(2014)
Cas No. | N/A | SDF | |
别名 | 溴化吡啶斯的明 d3 (溴盐) | ||
Canonical SMILES | O=C(N(C)C)OC1=C[N+](C([2H])([2H])[2H])=CC=C1.[Br-] | ||
分子式 | C9H10D3N2O2·Br | 分子量 | 264.1 |
溶解度 | Water: 100 mg/ml | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.7864 mL | 18.9322 mL | 37.8644 mL |
5 mM | 0.7573 mL | 3.7864 mL | 7.5729 mL |
10 mM | 0.3786 mL | 1.8932 mL | 3.7864 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet